Medidata Blog

Risk-Based Monitoring: Are CROs Poised to Deliver What Sponsor's Want?

Reading Time: < 1 minute

Following a panel discussion on risk-based monitoring (RBM), Medidata’s Lawrence Florin caught up with fellow panelist, Alison Taber (Theorem Clinical Research) and Strategies for Small to Mid-sized Pharma & Biotech Track Chairman, Mitchell Katz (Purdue Pharma) at the IIR 23rd Annual Partnerships in Clinical Trials event in Las Vegas. The panel discussion, "Risk-Based Study Management for Small to Mid-Sized Companies," focused on RBM adoption and implementation, from the small and mid-sized sponsor company, as well as contract research organization (CRO) and technology provider perspectives, collectively. In this video recap, Larry, Alison and Mitch continue the discussion, focusing on how CROs can meet varied sponsor expectations and collaboratively find more creative and complementary ways to leverage, people, process and technology to design, implement and derive benefit from RBM programs. *Guest blogger Lawrence Florin leads Consulting Partnerships at Medidata Solutions. *Guest blogger Alison Taber is VP, Global Data Management at Theorem Clinical Research. *Guest blogger Mitchell Katz serves as Executive Director, Medical Research Operations at Purdue Pharma, LP.

Medidata Solutions Image

Medidata Solutions